43rd week of 2016 patent applcation highlights part 9 |
Patent application number | Title | Published |
20160310442 | BETACRYPTOXANTHIN COMPOSITIONS, PROCESSES FOR PREPARATION AND USES THEREOF | 2016-10-27 |
20160310443 | FOOD AND BEVERAGE COMPOSITIONS INFUSED WITH LIPOPHILIC ACTIVE AGENTS AND METHODS OF USE THEREOF | 2016-10-27 |
20160310444 | REDUCTION OF ADIPOSE TISSUE | 2016-10-27 |
20160310445 | PREVENTION AND COUNTERACTION OF DIET-INDUCED THROMBOSIS RISK | 2016-10-27 |
20160310446 | Low Dose Topiramate/Phentermine Composition and Methods of Use Thereof | 2016-10-27 |
20160310447 | COMPOSITIONS AND METHODS FOR TREATING RESPIRATORY INJURY OR DISEASE | 2016-10-27 |
20160310448 | Adamantane or Pinene Derivatives for Use in the Treatment of Chlamydiales Infections | 2016-10-27 |
20160310449 | MODIFIED RELEASE FORMULATIONS CONTAINING DRUG - ION EXCHANGE RESIN COMPLEXES | 2016-10-27 |
20160310450 | d-Methadone for the Treatment of Psychiatric Symptoms | 2016-10-27 |
20160310451 | COMBINATION CANCER TREATMENT | 2016-10-27 |
20160310452 | Aerosol Formulations Comprising Formoterol Fumarate Dihydrate | 2016-10-27 |
20160310453 | COMBINATION OF IMMUNOTHERAPY WITH LOCAL CHEMOTHERAPY FOR THE TREATMENT OF MALIGNANCIES | 2016-10-27 |
20160310454 | LIVER X RECEPTOR AGONISTS IN THE TREATMENT OF EMPHYSEMA | 2016-10-27 |
20160310455 | Methods of inhibiting a bacterial virulence in a subject | 2016-10-27 |
20160310456 | COMPOSITIONS AND METHODS FOR USING SAME FOR REDUCING LEVELS OF ARACHIDONIC ACID IN TISSUE HAVING UNDERGONE AN INVASIVE PROCEDURE | 2016-10-27 |
20160310457 | PHARMACEUTICAL COMPOSITIONS COMPRISING DIMETHYL FUMARATE | 2016-10-27 |
20160310458 | COMPOUNDS USEFUL FOR INCREASING NEUROGENESIS IN NEURAL TISSUE | 2016-10-27 |
20160310459 | Fe(III) Complex Compounds For The Treatment And Prophylaxis Of Iron Deficiency Symptoms And Iron Deficiency Anemias | 2016-10-27 |
20160310460 | ITCH SUPPRESSION BY FUCOXANTHIN | 2016-10-27 |
20160310461 | Sulfamate Derivative Compound for Use in Preventing or Treating Epilepsy | 2016-10-27 |
20160310462 | PALYTOXYN, ITS MEDICAL USE AND PROCESS FOR ITS ISOLATION | 2016-10-27 |
20160310463 | LIQUID STATIN FORMULATION | 2016-10-27 |
20160310464 | METHOD OF DOSING AND USE OF SOFT ANTICHOLINERGIC ESTERS | 2016-10-27 |
20160310465 | SUBSTITUTED INDAZOLE DERIVATIVES ACTIVE AS KINASE INHIBITIORS | 2016-10-27 |
20160310466 | COMPOSITIONS AND METHODS FOR TREATING PRESBYOPIA, MILD HYPEROPIA, AND IRREGULAR ASTIGMATISM | 2016-10-27 |
20160310467 | ONDANSETRONE TO REVERSAL OF THE SOFT TISSUE ANESTHESIA | 2016-10-27 |
20160310468 | SUBSTITUTED IMIDAZOLES AS N-TYPE CALCIUM CHANNEL BLOCKERS | 2016-10-27 |
20160310469 | NOVEL USE OF BIOTIN AND NATURAL ESSENTIAL OILS FOR BOVINE ANIMALS TO IMPROVE BEEF QUALITY | 2016-10-27 |
20160310470 | ORODISPERSIBLE TABLETS | 2016-10-27 |
20160310471 | NOVEL GLP-1 RECEPTOR STABILIZERS AND MODULATORS | 2016-10-27 |
20160310472 | PHARMACEUTICAL COMPOSITIONS COMPRISING SULBACTAM AND IMIPENEM | 2016-10-27 |
20160310473 | COMBINATION THERAPIES FOR TREATMENT OF LAMINOPATHIES, CELLULAR AGING, AND ATHEROSCLEROSIS | 2016-10-27 |
20160310474 | N-BIARYLAMIDES | 2016-10-27 |
20160310475 | PROTEIN TYROSINE PHOSPHATASE INHIBITOR, PREPARATION METHOD AND USES THEREOF | 2016-10-27 |
20160310476 | CANCER TREATMENT USING COMBINATIONS OF ERK AND RAF INHIBITORS | 2016-10-27 |
20160310477 | CANCER TREATMENTS USING COMBINATIONS OF MEK TYPE 1 AND ERK INHIBITORS | 2016-10-27 |
20160310478 | MODIFIED RELEASE FORMULATIONS CONTAINING DRUG - ION EXCHANGE RESIN COMPLEXES | 2016-10-27 |
20160310479 | METHYLPHENIDATE EXTENDED RELEASE CHEWABLE TABLET | 2016-10-27 |
20160310480 | THERAPEUTICAL COMPOSITION CONTAINING APOMORPHINE AS ACTIVE INGREDIENT | 2016-10-27 |
20160310481 | LAQUINIMOD FOR TREATMENT OF CANNABINOID RECEPTOR TYPE 1(CB1) MEDIATED DISORDERS | 2016-10-27 |
20160310482 | METHOD FOR TREATING GEFITINIB RESISTANT CANCER | 2016-10-27 |
20160310483 | PYRIDINYL AND FUSED PYRIDINYL TRIAZOLONE DERIVATIVES | 2016-10-27 |
20160310484 | TREATMENTS FOR DEPRESSION AND OTHER DISEASES WITH A LOW DOSE AGENT | 2016-10-27 |
20160310485 | COMPOSITIONS AND METHODS FOR REDUCING MAJOR ADVERSE CARDIOVASCULAR EVENTS | 2016-10-27 |
20160310486 | TAMPER-RESISTANT FIXED DOSE COMBINATION PROVIDING FAST RELEASE OF TWO DRUGS FROM PARTICLES AND A MATRIX | 2016-10-27 |
20160310487 | TAMPER-RESISTANT DOSAGE FORM WITH IMMEDIATE RELEASE AND RESISTANCE AGAINST SOLVENT EXTRACTION | 2016-10-27 |
20160310489 | CARBOSTYRIL DERIVATIVES AND SEROTONIN REUPTAKE INHIBITORS FOR TREATMENT OF MOOD DISORDERS | 2016-10-27 |
20160310490 | SYK INHIBITORS | 2016-10-27 |
20160310491 | SELECTIVE CALCIUM CHANNEL ANTAGONISTS | 2016-10-27 |
20160310492 | Marker for Cancer Prognosis and Methods Related Thereto | 2016-10-27 |
20160310493 | USE OF PEMIROLAST IN THE TREATMENT OF ACUTE ASTHMA | 2016-10-27 |
20160310494 | HETEROCYCLIC COMPOUND | 2016-10-27 |
20160310495 | PHARMACEUTICAL COMPOSITIONS OF PEMETREXED | 2016-10-27 |
20160310496 | NOVEL TETRAHYDROPYRIDOPYRIMIDINE COMPOUND OR SALT THEREOF | 2016-10-27 |
20160310497 | PURINE DERIVATIVES USEFUL AS HSP90 INHIBITORS | 2016-10-27 |
20160310498 | Axillary Transdermal Compound Delivery System | 2016-10-27 |
20160310499 | Highly Active Anti-Neoplastic and Anti-Proliferative Agents | 2016-10-27 |
20160310500 | SEROTONIN-NOREPINEPHRINE REUPTAKE INHIBITORS (SNRIS) AND SIGMA RECEPTOR LIGANDS COMBINATIONS | 2016-10-27 |
20160310501 | GABAPENTINOIDS AND SIGMA RECEPTOR LIGANDS COMBINATIONS | 2016-10-27 |
20160310502 | NOVEL METHODS | 2016-10-27 |
20160310503 | Combination Therapies for the Treatment of Alzheimer's Disease and Related Disorders | 2016-10-27 |
20160310504 | INJECTABLE MIRTAZAPINE FOR TREATING APPETITE LOSS AND NUTRITIONAL DISORDERS IN CATS | 2016-10-27 |
20160310505 | PROSTAMIDES FOR ENHANCEMENT OF LEPTIN PRODUCTION | 2016-10-27 |
20160310506 | ORALLY DISINTEGRATING SOLID DOSAGE UNIT CONTAINING AN ESTETROL COMPONENT | 2016-10-27 |
20160310507 | OPTIMIZING MIFEPRISTONE LEVELS FOR CUSHING'S PATENTS | 2016-10-27 |
20160310508 | TESTOSTERONE GEL COMPOSITIONS AND RELATED METHODS | 2016-10-27 |
20160310509 | ALTERING STEROID METABOLISM FOR TREATMENT OF STEROID-DEPENDENT DISEASE | 2016-10-27 |
20160310510 | MEDICINAL COSMETIC LIPOATROPHY | 2016-10-27 |
20160310511 | Myxovirus Therapeutics, Compounds, and Uses Related Thereto | 2016-10-27 |
20160310512 | THERAPY REGIMEN FOR TREATING SEVERE ACNE RELATED DISEASES | 2016-10-27 |
20160310513 | SMALL MOLECULE ENHANCER FOR DENDRITIC CELL CANCER VACCINES | 2016-10-27 |
20160310514 | Synthetic composition for treating metabolic disorders | 2016-10-27 |
20160310515 | Water-Dispersible Supplements and Methods | 2016-10-27 |
20160310516 | CONJUGATE OF GINSENOSIDE COMPOUND K AND GLYCOL CHITOSAN AND AN ANTI-TUMOR USE THEREOF | 2016-10-27 |
20160310517 | NICOTINOYL RIBOSIDE COMPOSITIONS AND METHODS OF USE | 2016-10-27 |
20160310518 | BILE ACID RECYCLING INHIBITORS FOR TREATMENT OF PEDIATRIC CHOLESTATIC LIVER DISEASES | 2016-10-27 |
20160310519 | MODIFIED G-QUADRUPLEX NANOPARTICLES | 2016-10-27 |
20160310520 | METHOD AND PHARMACEUTICAL TO TREAT SPINAL DISCS | 2016-10-27 |
20160310521 | POLYSACCHARIDES COMPRISING TWO ANTITHROMBIN III-BINDING SITES, PREPARATION THEREOF AND USE THEREOF AS ANTITHROMBOTIC MEDICAMENTS | 2016-10-27 |
20160310522 | METHOD FOR PRODUCING COMPOSITE GEL BY CROSS-LINKING HYALURONIC ACID AND HYDROXYLPROPYL METHYLCELLULOSE | 2016-10-27 |
20160310523 | USE OF OXYGEN-CONTAINING GAS SOURCE | 2016-10-27 |
20160310524 | COMPOSITIONS AND METHODS FOR TREATING DYSREGULATED SYSTEMS | 2016-10-27 |
20160310525 | PREPARATION FOR PREVENTION AND/OR TREATMENT OF PERI-IMPLANTITIS | 2016-10-27 |
20160310526 | Chlorite-Containing Compositions | 2016-10-27 |
20160310527 | COMPOSITIONS AND METHODS COMPRISING ENERGY ABSORBING COMPOUNDS FOR FOLLICULAR DELIVERY | 2016-10-27 |
20160310528 | Castration-Resistant Prostate Cancer | 2016-10-27 |
20160310529 | NUTRITION, EXERCISE AND COGNITIVE DEVELOPMENT | 2016-10-27 |
20160310530 | TETRASPANIN CD82 AS A DIAGNOSTIC AND/OR THERAPEUTIC MODULE FOR XENOGRAFT RECOGNITION AND/OR REJECTION | 2016-10-27 |
20160310531 | COMBINATION OF PHARMACEUTICAL PREPARATIONS FOR TUMOR CHEMOTHERAPY | 2016-10-27 |
20160310532 | NKT-CELL SUBSET FOR IN VIVO PERSISTENCE AND THERAPEUTIC ACTIVITY AND PROPAGATION OF SAME | 2016-10-27 |
20160310533 | USE OF A SWEET WHEY CONTAINING INFANT FORMULA FOR PROMOTING THE POSTNATAL NEURONAL DEVELOPMENT OF THE INFANT GASTROINTESTINAL TRACT, AND THE ESTABLISHMENT OF THE INTESTINAL FUNCTIONS THAT IT CONTROLS | 2016-10-27 |
20160310534 | PHARMACEUTICAL COMPOSITION FOR TREATING CEREBROVASCULAR DISEASES, CONTAINING STEM CELL-DERIVED EXOSOME AS ACTIVE INGREDIENT | 2016-10-27 |
20160310535 | Transdiscal Administration Of Specific Inhibitors Of Pro-Inflammatory Cytokines | 2016-10-27 |
20160310536 | Transdiscal Administration Of Specific Inhibitors Of Pro-Inflammatory Cytokines | 2016-10-27 |
20160310537 | Transdiscal Administration Of Specific Inhibitors Of Pro-Inflammatory Cytokines | 2016-10-27 |
20160310538 | Transdiscal Administration Of Specific Inhibitors Of Pro-Inflammatory Cytokines | 2016-10-27 |
20160310539 | Transdiscal Administration Of Specific Inhibitors Of Pro-Inflammatory Cytokines | 2016-10-27 |
20160310540 | METHODS OF USING REGENERATIVE CELLS TO PROMOTE WOUND HEALING | 2016-10-27 |
20160310541 | A CHAMBER FOR ENCAPSULATING SECRETING CELLS | 2016-10-27 |
20160310542 | Extracellular Matrix Material Particles and Methods of Preparation | 2016-10-27 |